Description
This monthly meeting is open to to public. Members of the Cambridge Biosafety Committee may conduct its oversight activities as granted under the Cambridge Recombinant DNA Technology Ordinance (Chapter 8.20) and the Cambridge Biosafety Regulation of 2009.
July 21, 2016 Agenda
- StreetBio (David Kong) will present a request for a new BSL-1 permit for their facility at 934 Massachusetts Avenue.
- Sigilon, Inc. (Omid Veiseh) will present a request for a new BSL-1/BSL-2 permit for their facility at 161 First Street, 1st Floor.
- Goldfinch Bio (Peter Mundel) will present a request for a new BSL-1/BSL-2 permit for their facility at 215 First Street.
Old Business/Site visits
6/28 – Relay Therapeutics (215 First Street, 3rd Floor) – New permit walkthrough for BSL-1/BSL-2
7/7 – StreetBio walkthrough (934 Mass. Ave) – New permit walkthrough for BSL-1
7/20 – Mass Innovation Labs walkthrough (675 W Kendall St) – New permit walkthrough BSL-1/BSL-2
New Business
Adjourn